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Abstract: The purpose of the present study was to use capacitive coupling of pulsed 
electromagnetic field (CC-PEMF) and hydroxyapatite nanoparticles (HAp) as a counter-
measure to prevent osteoporosis induced by simulated microgravity. We used the hind-limb 
suspension (HLS) rat model to simulate microgravity-induced bone losses for 45 days. In order 
to compare the resulting changes, mineralogical (bone mineral density [BMD], calcium [Ca], 
and phosphorus [P]), biochemical (osteocalcin, alkaline phosphatase [ALP], and type I collagen), 
and histological (scanning electron microscopy) parameters were adopted. As a countermea-
sure to the above, the effect of PEMF and HAp application were examined. Three-month-old 
female Wistar rats were randomly divided into control (n = 8), HLS (n = 8), HLS with PEMF 
(n = 8), HLS with HAp nanoparticles (n = 8), and HLS with HAp and PEMF (n = 8). We 
observed: 1) significant decrease (p  0.01) in BMD, Ca, P, type I collagen, and ALP activity 
in femur and tibia in hind-limb bone and serum osteocalcin in HLS rats as compared with 
the ground control. 2) Nonsignificant increase in BMD (p  0.1), Ca (p  0.1), P (p  0.5), 
type I collagen (p  0.1), and ALP activity (p  0.5) in femur and tibia in hind-limb bone 
and serum osteocalcin (p  0.5) in HLS + PEMF rats compared with HLS rats. 3) Significant 
increase in BMD (p  0.02), Ca (p  0.05), P (p  0.05), type I collagen (p  0.02), and 
ALP activity (p  0.02) in femur and tibia in hind-limb bone with a nonsignificant increase in 
serum osteocalcin (p  0.1) in HLS + HAp rats compared to HLS rats. 4) Significant increase 
in BMD (p  0.01). Ca (p  0.01). P (p  0.01). type I collagen (p  0.01). and ALP activity 
(p  0.01) in femur and tibia in hind-limb bone and serum osteocalcin (p  0.02) were also 
observed. Results suggest that a combination of low level PEMF and Hap nanoparticles has 
potential to control bone loss induced by simulated microgravity.
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Introduction
Removal of gravity during long-duration space flight results in a loss of homeostasis 
in the skeleton. which adapts to the new environment by shedding calcium1 at a rate 
that is almost 10 times greater than that in a postmenopausal women2,3 and loss of 
bone mineral density (BMD).4–6 Microgravity changes the metabolic environment 
of bone leading to site-specific alterations in bone remodeling. Bone formation is 
decreased and bone resorption is increased,7 which results in significant bone loss 
with a consequent increase in fracture risk. Over the past few years, several counter-
measures have been examined to prevent bone loss during exposure to microgravity, International Journal of Nanomedicine 2009:4 134
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including pharmacological therapy with calcitonin and 
bisphosphonates and several active and passive exercise 
regimes, but positive outcomes have been limited.8,9 The 
hind-limb elevation model (hind-limb suspension [HLS]: 
tail-suspended model) in rats has been shown to simulate 
the bone turnover and muscle changes seen in growing rats 
during space flight.10,11 This model mimics microgravity, 
which affects musculoskeletal systems, metabolic changes 
altering bone formation compared with those recorded for 
biosatellite animals.12
We have demonstrated that capacitive coupling of pulsed 
electromagnetic fields (CC-PEMF) exposure promote the 
restoration of the bone loss in osteoporotic rat bones.13–15 
Other studies have also shown PEMF to have effects on 
many aspects of bone formation and healing. These include 
induced endothelial cell proliferation and capillary formation, 
which are integral to angiogenesis in the revascularization 
of healing bone fractures.16
Hydroxyapatite [HAp; Ca10(PO4)6-(OH)2] nanoparticles 
are chemically similar to the mineral component of bones 
and hard tissues in mammals. It is one of the few materials 
that are classified as bioactive, which means that it will 
support bone growth and osteointegration when used in 
orthopedics. Crystalline HAp particles are the typical mineral 
used in repair and may promote osteoblast cell adhesion.17,18 
These particles are plate-shaped and hundreds of nanometers 
long.19,20 It is suggested that the basic inorganic building 
blocks of bone may be these nanosized apatite particles.21 
Tens to hundreds of these nanoblocks, in the collagen 
matrix, combine into self-assembled biomaterials that have 
remarkable physical and chemical features22 such as unique 
mechanical strength, insensitivity to growth/dissolution, 
and flexible structure.23 Thus, features of HAp nanoparticles 
may more closely approximate features of HAp during 
biomineralization. Therefore, HAp nanoparticles may 
promote the adhesion, proliferation, and synthesis of alkaline 
phosphatase (ALP) in osteoblasts and lead to more rapid 
repair of hard tissue injury.24,25
In the view of the above and the demands of long-term 
spaceflight, it seems imperative that we look for some 
acceptable method to counter the problem of osteoporosis. 
Efficacy of electrostimulation has been identified as a safe 
and noninvasive method to counter bone loss. Since the loss 
of HAp is inevitable, it is suggested that it should also be used 
as an input to control the regime loss. A small current induced 
due to electostimulation may be a trigger to precipitate HAp 
crystals at the affected site. In the present work, we have 
adapted a synergistic effect of these two methods.
Materials and methods
Animals
Female Wistar rats (90 days old and of similar mean weight, 
230–250 gm body wt.) were obtained from the animal 
facility of Jawaharlal Nehru University, New Delhi. The 
animal experiment protocol was approved by the Institu-
tional Animal Ethics Committee (IAEC code no. 07/2008) 
at Jawaharlal Nehru University, New Delhi. Animals were 
randomly divided into following five groups: control, HLS, 
HLS with HAp nanoparticle (HLS + N), HLS with PEMF 
(HLS + P), HLS with PEMF and HAp (HLS + P + N). Eight 
animals were taken from each group.
The HLS model (tail-suspended model) mimics 
microgravity. For the HLS model, rats were fixed with a tail 
harness (Figure 1) which raised their hind-limbs 1 cm off the 
cage floor by a 30° head-down angle. The rats retained this 
position for 45 days. Tail suspension was also maintained 
during nanoparticle and PEMF treatments.
Treatments
Nanoparticle treatment
Silicon-substituted hydroxyapatite (Si-HAp) nanopowder 
(cat. no. 677418) purchased from Sigma-Aldrich Chemicals 
(St. Louis, MO, USA) was used in the present investigation. 
The biological activity of Si-HAp was shown to be enhanced 
by substitution of Si ions into a fraction of hydroxyapatite 
lattice phosphate sites.26 Therefore, we used Si-substituted 
hydroxyapatite nanopowder instead of  pristine HAp 
nanopowder (Table 1).
In preparation of a solution of Si-HAp, Si-HAp nanopow-
der is mostly insoluble. To prepare the homogenous solution 
for injection, we added the nanopowder to phosphate-
buffered saline (PBS; 1x, pH 7.4) and dispersed the particles 
Figure 1 Pulsed electromagnetic field treatment by bone stimulator.International Journal of Nanomedicine 2009:4 135
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within the PBS solution with an Elma Ultrasonicator (Elma 
Hans Schmidbauer GmbH and Co KG, Singen, Germany) 
for 15 min at 130 KHz, 25 °C.
20 mg/250 gm body weight of this Si-HAp solution was 
injected intraperitoneally daily for 45 days.
PEMF treatment
Bone stimulator
Our device, known as an electrical bone stimulator, has 
been used to treat fractures and control osteoporosis.13–15 
It emits a PEMF, which is applied to the chosen site of the 
long bone. The bone stimulator (Table 2) is connected to a 
pair of capacitor electrodes, which are applied over the skin. 
It emits low level electromagnetic energy.
Calibration was done with the help of an Iwatsu oscillo-
scope (SS–5711 C; Iwatsu Electric Co., Ltd., Tokyo, Japan) 
and the output of our bone stimulator was given by a pair 
of electrodes to both hind limbs of each rat in the groups, 
HLS + P and HLS + P + N (Figure 1) for 45 days, four hours 
per day. Treatments were given for 45 days simultaneously 
to examine the efficacy of the countermeasure as compared 
with all other groups.
Mineralogical analysis
Bone samples preparation
Rats were sacrificed by an intraperitonial overdose of 
phenobarbital sodium. The femur and tibia of the hind limbs 
of all rat groups were dissected and freed from soft tissues 
and stored at −20 °C for various assays. The volumes of 
all fresh bones were measured by submersion of bone in 
a water-filled container with a scale sensitivity of 0.01 ml. 
After measuring the volume, bones were lyophilized for 
10 hours and powdered down into fine particles with mortar 
and pestle. Powdered samples were kept at 60 °C overnight 
in vacuum oven to determine total dry bone weight (organic + 
inorganic contents).
Mineral and organic content
Bone samples were kept at 700 °C in a muffled furnace 
(Widsons Scientific Works, Delhi, India) for 10 hours. The 
ash weight indicated the bone mineral content (BMC). The 
difference in dry bone and ash weight measured as organic 
content and parameters were calculated by the following 
formula (BMC = ash weight [mg]):
BMD
BMC
BoneVolume
=
Archimedes’ principle was applied to determine BMD 
(gm/cm3).
Calcium analysis
Calcium content was determined in rat bone samples by atomic 
absorption spectroscopy (AAS). Before analysis, powdered 
bone samples were digested in acid and then calcium was 
quantified by flame atomic absorption spectrophotometry 
(AA-6800; Shimadzu Scientific Instruments, Columbia, 
MD, USA). Bone powder (50 mg) from each sample was 
digested in 5 ml of aquaregia and heated in Teflon bomb 
at 100 °C for 10 hours. Subsequently, the digested samples 
were diluted with Milli-Q® (Millipore, Billerica, MA, USA) 
pure water and 100 ml stock solution was made. Stock 
solution (5 ml) was added with 95 ml of 0.5% lanthanum 
chloride and filtered through 0.45 µm pore size filter. The 
standards of different calcuim concentrations (ie, 1 ppm, 
2 ppm, 4 ppm, 5 pmm, and 10 pmm) were prepared from 
commercial standard solution (Ranbaxy Laboratories Ltd, 
Gurgaon, India). The standards and sample solutions were 
read against the blank solution. The concentration of calcium 
in the samples were calculated by equation obtained from 
the standard curve (R2 = 0.944).
Phosphorus analysis
Phosphorus analysis of bone samples was performed by 
vanadomolybdophosphoric acid colorimetric method 
in UV–VIS spectrophotometer (Varian AA-20; Varian 
Analytical Instruments, Palo Alto, CA, USA). 50 mg of dry 
bone powder from each sample was digested in mixture of 
1 ml H2SO4 and 5 ml of HNO3 and heated till the volume 
Table 1 Properties of Si-HAp
Molecular formula [Ca5(OH)(PO4)3]x
Molecular weight 502.31
Form Nanopowder, solid
Contains 5 wt. % silica as dopant (synthetic)
Particle size 200 nm (BET)
Abbreviations: HAp, hydroxyapatite nanoparticle; Si, silicon.
Table 2 We used a bone stimulator with following specifications 
for exposure
Carrier frequency 14.0 MHz
Modulated frequency 16.0 Hz
Amplitude 10 V (peak to peak)
Output wave shape Square
Electrode diameter 1 cm
Average electric field between electrodes 7.8 Volt/mInternational Journal of Nanomedicine 2009:4 136
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became 1 ml (complete removal of HNO3). Thereafter the 
solution was neutralized and 100 ml sample stock solution 
was prepared with double-distilled water. 5 ml of sample 
stock solution was added to 30 ml of double-distilled water 
and 15 ml of Vanadate-Molybdate reagent (VMR) and 
filtered through 0.45 µm pore size filter paper (Millipore). 
Phosphorus concentrations were evaluated with respect to 
standard solutions of 0.2 ppm, 0.4 ppm, 0.6 ppm, 0.8 ppm, 
and 1 ppm concentration from phosphate (KH2PO4) standard 
stock solution. The standards and samples were read against 
the blank solution at 470 nm wavelength. The readings 
of sample solutions, standard, and blank were noted. The 
concentration of phosphorus in the samples was calculated 
by standard curve (R2 = 0.9976).
X-ray diffraction
The procured bone samples were cleaned well to remove 
macroscopic adhering impurities. In order to avoid soot and 
crack formation during heat treatment, the bone samples 
were boiled in distilled water for two hours. After boiling, 
the bone samples were immersed in 2% NaCl solution as a 
preservative for two hours and then these were degreased by 
immersing in acetone-ether mixture (in the ratio of 3:2 for 
two hours). Thereafter samples were stored at −20 °C until 
assay. The bone samples were then preheated overnight at 
700 °C (Widsons Scientific Works). X-ray diffraction (XRD) 
patterns were obtained with a X’Pert Philips Analytical 
X-ray diffractometer (PANalytical India, Delhi, India) 
with CuKα (λ = 1.543 Å) incident radiation and operated 
at 45 kV and 35 mA. The XRD peaks were recorded in the 
range of 10°–90°.
Histological analysis
Scanning electron microscopy
The femur and tibia of each of the five groups of rats were 
dissected and stripped of all soft tissues. Transverse sections 
of 0.5 cm thickness of femur and tibia hind-limb were made 
in all the five groups of bone samples. These were fixed in 
2% glutaraldehyde. Before doing any scanning electron 
microscope (SEM) characterization, the bone samples were 
dried and mounted on circular disc stubs with adhesive. Gold 
coatings were applied at a thickness of about 20 nanometers, 
which is too thin to interfere with the dimensions of surface 
features. Coating was done with the help of sputter coater. 
The samples were placed in a small vacuum chamber. After 
introducing the argon gas in the chamber, an electric field was 
applied to cause removal of electron from the argon atoms 
and made them positively charged. The Ar ions were then 
attracted to a negatively charged piece of coated material. 
The Ar ions acted like sand in a sandblaster, which struck 
gold or carbon atoms from the surface of the foil. These 
gold atoms now settled onto the surface of the sample and 
produced a gold coating. SEM images were obtained on low 
vacuum SEM (Leo 435 VP; Carl Zeiss SMT, Cambridge, 
UK) at the National Facilities of Electron Microcopy, AIIMS, 
New Delhi, India.
Biochemical analysis
ALP activity estimation in bone sample
Phosphatases are enzymes which catalyze the splitting of 
a phosphate from monophosphoric esters. ALP, a mixture 
of isoenzymes from liver, bone, intestine, and placenta, has 
maximum enzyme activity at about pH 10.5. ALP measure-
ments are of particular interest in the investigation of bone 
diseases. Paranitrophenyl phosphate, which is colorless, is 
hydrolyzed by ALP at pH 10.5 and 37 °C to form yellow-
colored free paranitrophenol. The addition of NaOH stops the 
enzyme activity and the final color shows maximum absor-
bance at 405 nm. Process is same as in serum, but for bone 
ALP estimation, a homogenate was prepared for the assay.
Femur and tibia were removed and cleaned of all adherent 
soft tissues, stored at −20 °C until assayed. Samples of the 
bone (femur and tibia) were washed with physiological 
saline (0.9% NaCl) and blotted on filter paper. Each bone 
was homogenized in 2 ml of glycine buffer (pH 10.4) using a 
high-performance homogenizer. Homogenized samples were 
centrifuged for 20 min at 8000 g and 4 °C. The activity of 
ALP in supernatant of the femur and tibia were determined 
by Ecoline Alk Phosphatase analysis kit (Merck, Darmstadt, 
Germany). A working solution (substrate solution; disodium 
paranitrophenyl phosphate) of each vial was dissolved in 
10 ml buffer (ready to use and was supplied with kit).1 ml 
of working solution and 200 µl of sample supernatant were 
taken in a microcentrifuge tube. Before proceeding further, 
a temperature-controlled spectrophotometer (Varian AA-20) 
was calibrated at 405 nm wavelengths to zero with the blank. 
Absorbance reading was done at one-minute time intervals 
(0 min, 1 min, 2 min, 3 min, and 4 min) at 37 °C. ALP 
activity (IU/L) is liberated by millimoles of purine nucleo-
side phosphorylase (PNP) per minute at 37 °C incubation 
per liter sample. A0 (absorbance at 0 min), A1 (absorbance 
at 1 min), A2 (absorbance at 2 min), A3 (absorbance at 
3 min), and A4 (absorbance at 4 min) were read against 
blank (distilled water) and average change in absorbance 
per minute (Abs/min) was determined. Calculation of PNP 
per minute in m.mol/L or ALP activity in IU/L in the test International Journal of Nanomedicine 2009:4 137
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sample was carried out. At 37 °C, temperature factor (tf) at 
is equal to 1 and multiplication factor is 2757 (when 200 µl 
samples are taken).
Type I collagen estimation in bone samples
Bone samples were decalcified with EDTAG (0.5 M EDTA 
in 0.05 M Tris/HCl) and homogenized in 2 ml 0.05 M Tris/
HCl with proteinase inhibitor. Homogenized samples were 
lyophilized in vacuum drier for eight hours. Lyophilized 
samples were extracted with 2 ml of 0.5 M acetic acid for 
48 hours. The acetic acid soluble collagen was separated by 
centrifugation at 15000 g for 45 min. Supernatant of centri-
fuged material was transferred in a microcentifuge tube and 
the residue was subjected to subsequent digestion with pepsin 
(1 mg of pepsin/10 mg of lyophilized bone) in 2 ml of 0.5 M 
acetic acid (pH 2.0) for 48 hours. The pepsin-soluble colla-
gens were separated by centrifugation at 15000 g for 45 min. 
The pepsin-insoluble bone matrix was extracted with 0.05 M 
Tris/HCl, pH 7.5, containing 4.0 M guanidine hydrochloride 
for 24 hours. All three separated supernatant were fractionated 
by differential salt precipitation. Type I collagen molecules 
were precipitated with NaCl added to a final concentration 
of 2.6 M, pH 7.4, by stirring for 24 hours and centrifuged at 
15000 g for 45 min. Collected collagen precipitates were dis-
solved in 2 ml of 0.5 M acetic acid to make test sample stock 
solution. After preparation of sample stock solution, type I 
collagen standards were made with purified type I collagen 
from rat tail tendon (C7661-5MG; Sigma-Aldrich), 100 ml of 
1% Sirius Red (Direct Red 80, 43665, Fluka; Sigma-Aldrich) 
solution was prepared in 0.5 M acetic acid and was preserved 
for standard solution and test sample preparation.
The calibration graph was prepared using aliquots of 
type I collagen standard solution (Abs at 540 nm). The con-
centration of type I collagen was calculated in test samples 
with the help of an equation obtained by the calibrated 
graph. The sum of acid-soluble and enzyme collagen was 
considered as total collagen.
Osteocalcin estimation from serum
Osteocalcin from rat serum was measured by Rat Osteocalcin 
EIA Kit (cat. no. BT-490; Biochemical Technologies, Inc., 
Stoughton, MA, USA).
Assay principal
This sandwich ELISA Kit is specific for rat osteocalcin only. 
Both carboxylated and decarboxylated rat osteocalcin are 
recognized. Rat osteocalcin can be measured directly from 
serum, heparinized plasma, bone extracts, and serum-free 
cell culture supernates. A monoclonal antibody directed 
against the N-terminal region of osteocalcin is bound to the 
polystyrene wells. After incubation with sample, the plate 
is washed followed by incubation with a second antibody 
(goat polyclonal) of high specificity for the C-terminus of 
rat osteocalcin. Detection is achieved by a third incubation 
using a horseradish peroxidase conjugate of a donkey anti-
goat immunoglobulin G (IgG) and subsequent enzyme 
assay. The osteocalcin concentration is proportional to color 
development. Standards of highly purified rat osteocalcin are 
used to generate a standard curve.
Sample preparation
Serum was diluted to 1/20 dilution with sample buffer, 
provided with the Rat Osteocalcin EIA Kit.
We followed the following procedure to measure the 
osteocalcin: Stock standard (100 ng/ml) was diluted with 
sample buffer in the range of 0.33 ng/ml to 20 ng/ml to make 
six standards in the range of 0.25 to 20 ng/ml. 0.3, 1.0, 2.5, 
5.0, 10, and 20 ng/ml for standard curve.100 µl of sample 
buffer (blank), standards, controls, and unknowns were 
pipetted into designated duplicate wells of ELISA plates 
provided with the kit and kept for incubation at 2–8 °C 
for 18–24 hours. Wells were aspirated completely and 
washed three times with 0.3ml PBS wash buffer.100 µl 
of the osteocalcin antiserum was added to each well and 
incubated in water bath at 37 °C for one hour. Again, plates 
were washed three times and100 µl of the diluted donkey 
anti-goat IgG peroxidase was added to each well and 
incubated at room temperature for one hour. One volume 
of 3,3,5,5-tetramethylbenzidine (TMB) solution (BT-497; 
Sigma-Aldrich) was mixed with one volume of hydrogen 
peroxide solution (BT-498; Sigma-Aldrich) and kept aside. 
Again, the plate was washed three times with washing buf-
fer and immediately 100 µl of substrate mix was added to 
all wells and incubated at room temperature in the dark for 
30 min. Finally, 100 µl of stop solution was added to all wells 
and absorbance was measured at 450 nm within 15 min.
Statistical analysis
All the experimental results were compared with control 
group where statistical analysis was done by one-way 
analysis of variance in mean ± standard deviation.
Results
Mineralogical analysis
To find out the deposition of hydroxyapatite crystal into 
osteoid, we measured the BMD, calcium, and phosphorus International Journal of Nanomedicine 2009:4 138
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content of the hind limb of all five rat groups (control, HLS, 
HLS + P, HLS + N, HLS + P + N groups; n = 8). The detailed 
results of BMD, calcuim, and phosphorus content in femur 
and tibia for different groups are presented in Figures 2(a, b), 
3(a, b), and 4(a,b), respectively.
The body weights at euthanasia (Table 3) suggest that 
with the application of PEMF+HAp, there is a reversal in 
the tendency of weight loss. This is evidenced by measured 
values of BMD, calcium, and phosphorus.
X-ray diffraction
The XRD method show the higher intensity record at an 
angle of 2θ = 32°, which is the characteristic diffraction 
angle for calcium hydroxyapatite. This also confirmed the 
crystallographic of deposits. The higher peak intensity 
in treated groups as compared to HLS indicated more 
deposition of hydroxyapatite in crystalline form. The 
detailed results are presented in Table 4. See Table 5 for 
the crystallographic parameters of HAp crystal deposited 
into the bone matrix.
Scanning electron microscopy
SEM was performed in all groups of bone samples to evaluate 
the changes in cortex and cancellous part of bone. Transverse 
section of femur and tibia bone of control, HLS, and treated 
(HLS + P, HLS + N, HLS + P + N) rats were analyzed. 
More compactness in cancellous part and mineral deposition 
in control and treated bone were found compared to HLS 
bone (Figures 5–8). Similar results were also obtained in 
cortical thickness among various rat groups (Figures 9–12). 
It was observed that bone marrow was attached to the cortex 
in treated groups was visible in normal controls. There was a 
deposition of white matter in HLS + P + N group rats, which 
may be a deposit of hydroxyapatite particles.
Biochemical analysis
Osteocalcin, ALP, and type I collagen were measured in all 
five rat groups.
Alkaline phosphatase activity
Alkaline phosphatase is involved in mineralization process 
and is a good marker of osteoblastic activity. ALP activity 
was measured in the femur and tibia of all rat groups. The 
result shows a significant increase. Detailed results of ALP 
activity in femur and tibia for the different groups are 
presented in (Figure 13a, b). It is evident that there is more 
activity in the femur as compared to tibia.
Type I collagen estimation  
in femur and tibia
Sirius Red, a strong anionic dye, stains collagen by reacting 
via its sulphonic acid groups, with the basic group present in 
collagen molecule. Collagen extracted with acetic acid and 
pepsin from bone samples of different groups was analyzed. 
The detailed results of type I collagen in the femur and tibia 
for different rat groups are presented in Figure 14 a, b.
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Figure 2 (A) BMD (mg/ml) in femur. (B) BMD (mg/ml) in tibia. Nonsignificant increase in HLS and HLS + P.
Notes: *Indicates significant difference between: 1) control and HLS; 2) HLS and HLS + N; 3) HLS and HLS + P + N.
Abbreviations: BMD, bone mineral density; HLS, hind-limb suspension; HLS + N, hind-limb suspension + nanoparticle (Si-HAp); HLS + P, hind-limb suspension + PEMF; 
HLS + P + N, hind-limb suspension + PEMF + nanoparticle; PEMF, pulsed electromagnetic field.International Journal of Nanomedicine 2009:4 139
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Osteocalcin estimation in serum
Osteocalcin, also known as bone Gla protein, is a marker of 
bone formation. It is the most abundant and widely studied 
noncollagenous protein produced by osteoblasts. The detailed 
results of osteocalcin concentration in serum of different 
groups are presented in Figure 15.
Discussion
It may be mentioned that to start with we have used ninety-
day-old rats, which implies that the period of observation 
extends from growing to maturing stage. After 45 days of 
HLS, we observed a significant decrease in BMD in HLS 
rats compared to ground control rats. However, there was a 
significant increase in BMD in treated rats compared to HLS 
rats (Figure 2 a, b), Correspondingly a decrease in calcium 
and phosphorus levels in HLS rats and increased levels in the 
treated rats (except HLS+P) corroborate the loss and regain 
of bone mass, respectively (Figures 3, 4).
Various crystallographic specifications for control and 
various treated samples were carried under identical situation. 
It may be noted that the 2θ position for samples remained 
unchanged for a given intensity maximum. The crystal size 
and type indicated by c and a (axial distance or edge length) 
values and corresponding α, β, γ (axial angles) in control and 
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Figure 3 (A) Calcium content in femur. (B) Calcium content in tibia. Nonsignificant increase in HLS and HLS + P.
Notes: *Indicates significant difference between: 1) control and HLS, 2) HLS and HLS + N, 3) HLS and HLS + P + N.
Abbreviations: HLS, hind-limb suspension; HLS + N, hind-limb suspension + nanoparticle (Si-HAp); HLS + P, hind-limb suspension + PEMF; HLS + P + N, hind-limb suspension + 
PEMF + nanoparticle; PEMF, pulsed electromagnetic field.
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Figure 4 (A) Phosphorus content in femur. (B) phosphorus content in tibia. Nonsignificant increase in HLS and HLS + P.
Notes: *Indicates significant difference between: 1) control and HLS, 2) HLS and HLS + N, 3) HLS and HLS + P + N.
Abbreviations: HLS, hind-limb suspension; HLS + N, hind-limb suspension + nanoparticle (Si-HAp); HLS + P, hind-limb suspension + PEMF; HLS + P + N, hind-limb suspension + 
PEMF + nanoparticle; PEMF, pulsed electromagnetic field.International Journal of Nanomedicine 2009:4 140
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treated samples are approximately the same. This provides 
support to our finding that treatment with nanoparticles and 
PEMF combined has a positive impact on restoring the bone 
loss. In HAp + PEMF treated sample rats, the peak position 
for the maximum intensity (100%) shift to slightly altered h, 
k, l and d values, while the 2θ position remains unchanged. 
From Table 4, it is apparent that due to the application of 
PEMF in HLS + P + N rats there is a change in density, 
volume of cell, and Z (charge). A change in the possible 
molecular composition may be caused by precipitation of 
HAp nanoparticles with negatively charged cationic region 
in collagen molecules at the osteoporotic site. An application 
of PEMF with the injection of HAp help in the deposition of 
extra carbon (C) and floride (F) in the bone matrix.
Alkaline phosphatase is produced in the bone’s cycle 
formation phase and, is therefore an excellent indicator of 
bone formation activity.27 Osteocalcin is the most abun-
dant noncollagenous protein in bone, and its concentra-
tion in serum is closely linked to bone metabolism and 
serves as a biological marker for the clinical assessment of 
bone disease, although its precise mechanism of action is 
unclear. Osteocalcin influences bone mineralization in part 
through its ability to bind with high affinity to the mineral 
component of bone, hydroxyapatite.28 It is observed that 
higher serum-osteocalcin levels are relatively well correlated 
with increases in BMD during treatment with anabolic bone 
formation drugs for osteoporosis. A significant increase in 
ALP and osteocalcin with increased BMD in HLS + HAp 
and HLS + HAp + PEMF rats compared to HLS rats indicate 
that enhanced bone formation has taken place. Although 
ALP and osteocalcin are the two primary bone markers for 
bone formation, use of type I collagen as reliable markers 
have also been tested. Increase in type I collagen in treated 
group rats suggests that mineralization has taken place with 
utmost fidelity.
An important but unsolved question is how the cells 
can recognize the particle size of HAp nanoparticles. It is 
well known that cells are inherently sensitive to their sur-
roundings. It is suggested that the dissolution of HAp 
nanoparticles (small size and poor crystallinity) will increase 
concentrations of calcium and phosphate in the medium and 
thereby may alter the gene expression, alkali phosphate and 
proteins.29 We observed significant increase in ALP activity, 
type I collagen. and osteocalcin concentration in HLS + HAp 
group rats. It indicates that 20 mg/250 gm body weight of 
Si-HAp can induce and enhance the expression level of bone 
Table 3 Body weights at euthanasia
Control 
(gm)
HLS (gm) HLS + P 
(gm)
HLS + HAp 
(gm)
HLS + P + N 
(gm)
291.25 ± 8.8 227.12 ± 6.5 238.87 ± 6.4 252.98 ± 7.8 271.6 ± 9.2
Note: Values are means ± SE.
Abbreviations: HAp, hydroxyapatite nanoparticle; HLS, hind-limb suspension; 
HLS + P, hind-limb suspension + PEMF; HLS + P + N, hind-limb suspension + PEMF + 
nanoparticle; PEMF, pulsed electromagnetic field; SE, standard error.
Table 4 Physical parameter of HAp crystal deposited into the bone matrix
Values 
Groups
2θ PDF Index name Chemical formula Density/volume/Z c(A°) a(A°) d(A°)
Control 32° Calcium Phosphate 
Hydroxide
Ca5(PO4)3(OH) 
a/c = 1.370
3.14/530.14/2.00 6.8810 9.4320 2.817
HLS 32° Calcium Phosphate 
Hydroxide
Ca5(PO4)3(OH) 
a/c = 1.370
3.14/530.14/2.00 6.8810 9.4320 2.817
HLS + P 32° Calcium Phosphate 
Hydroxide
Ca5(PO4)3(OH) 
a/c = 1.370
3.14/530.14/2.00 6.8810 9.4320 2.817
HLS + N 32° Calcium Phosphate 
Hydroxide
Ca5(PO4)3(OH) 
a/c = 1.370
3.14/530.14/2.00 6.8810 9.4320 2.817
HLS + P + N 32° Calcium carbonate 
Phosphate Fluoride 
Hydroxide
Ca10(PO4)5Co3(OH)F 
a/c = 1.371
3.05/527.04/1.00 6.8660 9.4147 2.717
Note: Z, charge.
Abbreviations: HAp, hydroxyapatite nanoparticle; HLS, hind-limb suspension; HLS + N, hind-limb suspension + nanoparticle (Si-HAp); HLS + P, hind-limb suspension + PEMF; 
HLS + P + N, hind-limb suspension + PEMF + nanoparticle; PDF, ; PEMF, pulsed electromagnetic field.
Table 5 Crystallographic parameter of HAp crystals deposited 
into the bone matrix
Crystal system Hexagonal
Space group P63/m
Space group number 176
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Figure 5 SEM image of cancellous part of femur (Control).
Abbreviation: SEM, scanning electron microscope.
Figure 6 SEM image of cancellous part of femur (HLS).
Abbreviations: HLS, hind-limb suspension; PEMF, pulsed electromagnetic field; SEM, 
scanning electron microscope.
Figure 7 SEM image of cancellous part of femur (HLS + P).
Abbreviations: HLS, hind-limb suspension + pulsed electromagnetic field; SEM, 
scanning electron microscope.
Figure 8 SEM image of cancellous part of femur (HLS + PEMF + HAp).
Abbreviations: HAp, hydroxyapatite nanoparticle; HLS, hind-limb suspension; PEMF, 
pulsed electromagnetic field;  SEM, scanning electron microscope.
formation marker genes. Furthermore, the zeta potential 
measurements can provide the interfacial properties of the 
nanoparticles. HAP particles have a negative zeta potential 
in water at pH 7.4.30 Since the electronic potential of cell 
membranes is known to be always negative; the positive or 
weakly negative particles are suitable for adsorption by cells. 
Another possible explanation is that the quantity of proteins 
adsorbed on particles positively correlates with their specific 
surface area.31 Nanosized particles adsorbed significantly 
greater amounts of proteins, and induce enhancement of 
subsequent cell adhesion and proliferation 32 in HLS + HAp 
and HLS + HAp + PEMF group rats. It is suggested that 
PEMF helps to accelerate the process.
The bilayer lipid structure of the plasma membrane and 
the electrical double layer at its inner and outer surfaces 
make the cell membrane a real capacitor, ie, a charge storage 
system. EMF exposure depolarizes the cell membrane of 
osteoblast to alter the uptake of calcium ions and increases 
the concentration of intracellular free calcium in osteoblast 
cytoplasm. Calcium influx is driven by induced polariza-
tion of plasma membrane when bone cells are exposed 
to external electric field via a classical second messenger 
mechanism and this eventually leads to a mitogenic effect. 
Electrical stimulation elevates the transmembrane voltage 
and results in the elevation of electrical conductivity 
of the cell membrane.33 Due to this effect, the function 
of cell membrane protein, lipids, as well as expression of 
genes alters and this leads to cell proliferation. In spite 
of four hours per day therapy by bone stimulator, in the 
PEMF-treated group (HLS+PEMF), we did not observe 
a significant increase in BMD, calcuim, phosphatase, International Journal of Nanomedicine 2009:4 142
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or ALP activity. Type I collagen, osteocalcin, and also the 
cortical thickness of femur and tibia bone in HLS + P rats 
were less than in other treated rat groups (HLS + P + N, 
HLS + N). This is attributed to the lack of adequate calcium 
in the body system (HLS + P). However, the beneficial effect 
of low-intensity electric stimulation (PEMF) on bone has 
been demonstrated in other models, such as sciatic neurec-
tomy and ovariectomy.13–15,34
HAp and PEMF both have a propensity to enhance the 
expression level of bone formation marker by different 
mechanisms. PEMF increase growth factors such as 
insulin-like growth factor II (IGF-II), IGF-I, tumor growth 
factor- β (TGF-β) mRNA; modulate Ca2+ binding to CaM, 
upregulation of mRNA for bone morphogenetic protein-2 
(BMP-2) and BMP-4.35,36
(A) (B) 
Figure 9 (A) SEM image of cortical part of femur (Control). (B) SEM image of 
cortical part of femur (HLS).
Abbreviations: HLS, hind-limb suspension; SEM, scanning electron microscope.
(A) (B) 
Figure 10 (A) SEM image of cortical part of femur (HLS + P). (B) SEM image of 
cortical part of femur (HLS + P + N).
Abbreviations: HLS + P, hind-limb suspension + PEMF; HLS + P + N, hind-limb 
suspension + PEMF + nanoparticle; SEM, scanning electron microscope.
(A) (B)
Figure 11 (A) SEM image of cortical part of tibia (Control). (B) SEM image of 
cortical part of tibia (HLS).
Abbreviations: HLS, hind-limb suspension; SEM, scanning electron microscope.
(A) (B) 
Figure 12 (A) SEM image of cortical part of tibia (HLS + P). (B) SEM image of 
cortical part of tibia (HLS + N + P).
Abbreviations: HLS + P, hind-limb suspension + PEMF; HLS + N + P, hind-limb 
suspension + nanoparticle + PEMF; PEMF, pulsed electromagnetic field; SEM, scanning 
electron microscope.
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(A)
Figure 13 (A) ALP activity in femur. (B) ALP activity in tibia. Nonsignificant increase 
in HLS and HLS + P.
Notes: *Indicates significant difference between: 1) control and HLS, 2) HLS and 
HLS + N, 3) HLS and HLS + P + N.
Abbreviations: ALP, alkaline phosphatase; HLS, hind-limb suspension; HLS + N, 
hind-limb suspension + nanoparticle (Si-Hap); HLS + P, hind-limb suspension + 
PEMF; HLS + P + N, hind-limb suspension + PEMF + nanoparticle; PEMF, pulsed 
electromagnetic field.International Journal of Nanomedicine 2009:4 143
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Conclusion
HAp nanoparticles adsorb significantly greater amounts of 
proteins and induce enhancement of subsequent cell adhe-
sion and proliferation. When we used them synergistically, 
an increase in BMD, calcuim, phosphatase, ALP, type I 
collagen, and osteocalcin levels in HLS + P + N treated rats 
were observed as compared to HLS + N and HLS + P treated 
rats. Also, the mineral levels achieved after (HAp + PEMF) 
are comparable to ground animal data, suggesting that the 
treatment closely offsets the bone loss induced by microgravity. 
Hence, PEMF along with HAp is a positive countermeasure 
to prevent osteoporosis in simulated microgravity.
Disclosure
The authors report no conflicts of interest in this work.
References
  1.  Li J, Sarosi I, Yan XQ, et al. RANK is the intrinsic hematopoietic 
cell surface receptor that controls osteoclastogenesis and regulation 
of bone mass and calcium metabolism. Proc Natl Acad Sci U S A. 
2000;97:566–571.
  2.  Iki M, Kajita E, Dohi Y, et al. Age, menopause, bone turnover markers 
and lumbar bone loss in healthy Japanese women. Maturitas. 1996;25: 
59–67.
  3.  Sirola J, Kroger H, Honkanen R, et al. Factors affecting bone loss around 
menopause in women without HRT: a prospective study. Maturitas. 
2003;45:159–167.
  4.  Convertino VA, Sandler H. Exercise countermeasures for spaceflight. 
Acta Astronaut. 1995;35:253–270.
  5.  Rambaut PC, Leach CS, Whedon GD. A study of metabolic balance 
in crew members of Skylab IV. Acta Astronaut. 1979;6:1313–1322.
  6.  Whedon GD, Lutwak L, Reid J, et al. Mineral and nitrogen balance 
study: results of metabolic observations on Skylab II 28-day orbital 
mission. Acta Astronaut. 1975;2:297–309.
  7.  Smith BJ, King JB, Lucas EA, Akhter MP, Arjmandi BH, Stoecker BJ. 
Skeletal unloading and dietary copper depletion are detrimental to 
bone quality of mature rats. J Nutr. 2002;132:190–196.
  8.  Derendorf H. Pharmacokinetic/pharmacodynamic consequences of 
space flight. J Clin Pharmacol. 1994;34:684–691.
  9.  Czarnik TR, Vernikos J. Physiological changes in spaceflight that may 
affect drug action. J Gravit Physiol. 1999;6:161–164.
10.  Jee WSS, Wronski TJ, Morey ER, Kimmel DB. Effects of spaceflight 
on trabecular bone in rat. Am J Physiol. 1983;244: 310–314.
11.  Ilyina-Kakueva EI, Portugalov VV, Krivenkova NP. Spaceflight effects  on 
the skeletal muscles of rats. Aviat Space Environ Med. 1976;47:700–703.
12.  Wimalawansa SM, Wimalawansa SJ. A novel pharmacological 
approach of musculoskeletal losses associated with simulated micro-
gravity. J Musculoskel Neuron Interact. 2000;11:35–41.
13.  Behari J, Arya VP, Alex ZC. Bone fracture healing using a capacita-
tively coupled RF field. J Bioelect. 1991;10:1 231–239.
14.  Jayanand Behari J, Lochan R. Effects of low level pulsed radio fre-
quency fields on induced osteoporosis in rat bone. Indian J Exp Biol. 
2003;41:581–586.
Control
HLS
HLS
HLS + P
HLS
HLS + N
HLS
HLS + P + N 0
5
10
15
20
25
30
35
O
s
t
e
o
c
a
l
c
i
n
 
c
o
n
c
 
(
n
g
/
m
l
)
*P < 0.01
  P < 0.5
 P < 0.1
*P < 0.02
Figure 15 Total osteocalcin present in serum of different groups.
Notes: *Indicates significant difference between: 1) control and HLS, 2) HLS and 
HLS + P + N.
Abbreviations: HLS, hind leg-suspension; HLS + P + N, hind-limb suspension + pulsed 
electromagnetic field + nanoparticle.
(A)
Control
HLS
HLS
HLS + P
HLS
HLS + N
HLS
HLS + P + N
Control
HLS
HLS
HLS + P
HLS
HLS + N
HLS
HLS + P + N 0
500
1000
1500
2000
2500
3000
3500
T
y
p
e
 
I
 
c
o
l
l
a
g
e
n
*P < 0.01
  P < 0.5
 *P < 0.02
*  P < 0.01
0
200
400
600
800
1000
1200
1400
1600
1800
2000
T
y
p
e
 
I
 
c
o
l
l
a
g
e
n
*P < 0.01
  P < 0.1
 *P < 0.01
*  P < 0.01
(B) 
Figure 14 (A) Total type I collagen (µg/mg of dry weight) in femur. (B) Total type I collagen (µg/mg of dry weight) in tibia. Nonsignificant increase in HLS and HLS + P.
Notes: *Indicates significant difference between: 1) control and HLS, 2) HLS and HLS + N, 3) HLS and HLS + P + N.
Abbreviations: HLS, hind-limb suspension; HLS + N, hind-limb suspension + nanoparticle (Si-HAp); HLS + P, hind-limb suspension + PEMF; HLS + P + N, hind-limb suspension + 
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